Completed PHASE3 INTERVENTIONAL NCT00438061

Effect of Abdominal Obesity on Lipoprotein Metabolism

Effect of Weight Loss on Lipoprotein Metabolism in Abdominal Obesity

Sponsor: The University of Western Australia

Conditions Dyslipidemia Insulin Resistance Obesity

Interventions Weight loss by dietary restriction

Updated 5 times since 2017 Last updated: Feb 23, 2007 Started: Jan 31, 1995 Completion: Dec 31, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Dyslipidemia and Insulin Resistance, this trial is completed. The trial is conducted by The University of Western Australia and has accumulated 5 data snapshots since 1995. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1995

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The University of Western Australia

Data source: The University of Western Australia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Perth, Australia